Whereas IGF-I replacement therapy significantly reduced hyperglucemia and hyperinsulinemia in old rats diminishing insulin resistance index (HOMA) [4], non-relevant effects were induced by IGF-II since hyperglucemia was not reduced. This evidence concerns the gene IGF1 and hyperinsulinism.